↓ Skip to main content

Serum Levels of Soluble Urokinase Plasminogen Activator Receptor Predict Tumor Response and Outcome to Immune Checkpoint Inhibitor Therapy

Overview of attention for article published in Frontiers in oncology, April 2021
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (69th percentile)
  • High Attention Score compared to outputs of the same age and source (88th percentile)

Mentioned by

twitter
7 X users

Citations

dimensions_citation
10 Dimensions

Readers on

mendeley
19 Mendeley